China Journal of Leprosy and Skin Diseases ›› 2021, Vol. 37 ›› Issue (8): 525-527.doi: 10.12144/zgmfskin202108525

• Case Reports • Previous Articles     Next Articles

Recombinant human tumor necrosis factor receptor type II-IgG Fc fusion protein with glucocorticoid successfully treat Stevens-Johnson syndrome: a case report

LU Wenhua, GUO Jia, CAO Duling, ZHU Wu   

  1. Department of Dermatology, Xiangya Hospital of Central South University, Changsha 410008, China
  • Online:2021-08-15 Published:2021-07-21
  • Contact: ZHU Wu, E-mail: zhuwu70@hotmail.com

PDF (PC)

221

Like

Abstract: A 35-year-old female with erythema and blisters on trunk and limbs for 8 days. The clinical manifestations and the features of histological examination were consistent with drug-induced Stevens-Johnson syndrome (SJS). After one time injection with recombinant human tumor necrosis factor receptor type II-IgG Fc fusion protein and glucocorticoid, she recovered without recurrence.

Key words: Stevens-Johnson syndrome, recombinant human tumor necrosis factor receptor type II-IgG Fc fusion protein, TNF-α inhibitor